Literature DB >> 15086480

The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function.

Katsuhiko Yonemura1, Reiko Takahira, Osamu Yonekawa, Naohiro Wada, Akira Hishida.   

Abstract

BACKGROUND: We have previously reported that the serum concentration of 2-(alpha-mannopyranosyl)-L-tryptophan (MPT), tryptophan glycoconjugate, is a more accurate measure of renal function than that of serum creatinine concentration. The aim of the present study was to compare the diagnostic value of serum concentrations of MPT and creatinine as a measure of normal renal function.
METHODS: A total of 156 subjects with serum creatinine concentration < or =1.60 mg/dL aged 0 to 88 years were recruited. Serum concentrations of MPT and creatinine, and creatinine clearance calculated by Cockcroft-Galt formula were determined. A diagnostic accuracy of serum concentrations of MPT and creatinine for normal renal function was analyzed by using receiver-operating characteristics (ROC) curves. In 82 subjects with normal renal function defined as calculated creatinine clearance > or =80 mL/min (aged 6 to 68 years), the correlations between age and/or urinary creatinine excretion, which is related to muscle mass, and serum concentrations of MPT or creatinine, were determined.
RESULTS: In the ROC curve, the area under the curve (AUC) in serum MPT concentration was significantly greater than that of creatinine (0.855 versus 0.800, respectively, P < 0.001) and the cut-off levels associated with the greatest diagnostic accuracy were 90 ng/mL for serum MPT concentration and 0.70 mg/dL for serum creatinine concentration. The sensitivity, specificity, and positive and negative predictive values were 69.5%, 85.1%, 83.8%, and 71.6% for serum MPT concentration, and 53.7%, 81.1%, 75.9%, and 61.2% for serum creatinine concentration. A close correlation existed between serum creatinine concentration and age (r= 0.798, P < 0.0001) in 23 subjects aged 20 years or younger. Conversely, serum MPT concentration remained unchanged regardless of age (r=-0.135, P= 0.228). Furthermore, a close correlation existed between serum creatinine concentration and urinary creatinine excretion (r= 0.817, P < 0.0001), but not between serum MPT concentration and urinary creatinine excretion (r= 0.082, P= 0.461).
CONCLUSION: The concentration of serum MPT is a more reliable diagnostic parameter than that of serum creatinine as a measure of normal renal function, and renal function can be compared in subjects independently of age and muscle mass when serum MPT concentration is measured.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086480     DOI: 10.1111/j.1523-1755.2004.00521.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort.

Authors:  Jiaqi Huang; Stephanie J Weinstein; Steven C Moore; Andriy Derkach; Xing Hua; Linda M Liao; Fangyi Gu; Alison M Mondul; Joshua N Sampson; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

2.  Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study.

Authors:  Jøran Hjelmesæth; Jo Røislien; Njord Nordstrand; Dag Hofsø; Helle Hager; Anders Hartmann
Journal:  BMC Endocr Disord       Date:  2010-04-18       Impact factor: 2.763

3.  A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population.

Authors:  Peggy Sekula; Oemer-Necmi Goek; Lydia Quaye; Clara Barrios; Andrew S Levey; Werner Römisch-Margl; Cristina Menni; Idil Yet; Christian Gieger; Lesley A Inker; Jerzy Adamski; Wolfram Gronwald; Thomas Illig; Katja Dettmer; Jan Krumsiek; Peter J Oefner; Ana M Valdes; Christa Meisinger; Josef Coresh; Tim D Spector; Robert P Mohney; Karsten Suhre; Gabi Kastenmüller; Anna Köttgen
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

Review 4.  Why Is the GFR So High?: Implications for the Treatment of Kidney Failure.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2020-12-10       Impact factor: 10.614

5.  Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt Nephropathy.

Authors:  Ji Hye Huh; Soo In Choi; Jung Soo Lim; Choon Hee Chung; Jang Yel Shin; Mi Young Lee
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  Significant association of serum creatinine with HbA1C in impaired glucose tolerant Pakistani subjects.

Authors:  Tasnim Farasat; Saima Sharif; Shagufta Naz; Sabiha Fazal
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

7.  Metabolomic markers reveal novel pathways of ageing and early development in human populations.

Authors:  Cristina Menni; Gabriella Kastenmüller; Ann Kristin Petersen; Jordana T Bell; Maria Psatha; Pei-Chien Tsai; Christian Gieger; Holger Schulz; Idil Erte; Sally John; M Julia Brosnan; Scott G Wilson; Loukia Tsaprouni; Ee Mun Lim; Bronwyn Stuckey; Panos Deloukas; Robert Mohney; Karsten Suhre; Tim D Spector; Ana M Valdes
Journal:  Int J Epidemiol       Date:  2013-07-08       Impact factor: 7.196

8.  Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals.

Authors:  Maik Pietzner; Anne Kaul; Ann-Kristin Henning; Gabi Kastenmüller; Anna Artati; Markus M Lerch; Jerzy Adamski; Matthias Nauck; Nele Friedrich
Journal:  BMC Med       Date:  2017-11-30       Impact factor: 8.775

9.  Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.

Authors:  Monika A Niewczas; Tammy L Sirich; Anna V Mathew; Jan Skupien; Robert P Mohney; James H Warram; Adam Smiles; Xiaoping Huang; Walker Walker; Jaeman Byun; Edward D Karoly; Elizabeth M Kensicki; Gerard T Berry; Joseph V Bonventre; Subramaniam Pennathur; Timothy W Meyer; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

10.  Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.

Authors:  Elisabeth Altmaier; Gisela Fobo; Margit Heier; Barbara Thorand; Christine Meisinger; Werner Römisch-Margl; Melanie Waldenberger; Christian Gieger; Thomas Illig; Jerzy Adamski; Karsten Suhre; Gabi Kastenmüller
Journal:  Eur J Epidemiol       Date:  2014-05-10       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.